|
Re: Epigenetics article,...
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 10:53PM
|
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 10:12PM
|
|
American Diabetes Association Meeting, June 7-11, 2019
|
1
|
Resverlogix Corp.
|
Jun 04, 2019 10:09PM
|
|
Re: Final Short Term Prospectus and other Related Documents now on SEDAR
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 02:29PM
|
|
Re: Final Short Term Prospectus and other Related Documents now on SEDAR
|
4
|
Resverlogix Corp.
|
Jun 04, 2019 01:56PM
|
|
Final Short Term Prospectus and other Related Documents now on SEDAR
|
5
|
Resverlogix Corp.
|
Jun 04, 2019 01:02PM
|
|
Re: Radio Silence
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 03:59PM
|
|
Re: A healthy debate....
|
7
|
Resverlogix Corp.
|
Jun 03, 2019 01:13PM
|
|
NLRP3 inhibitors stoke anti-inflammatory ambitions
|
1
|
Resverlogix Corp.
|
Jun 03, 2019 12:00PM
|
|
Re: CKD & VCD clarification
|
4
|
Resverlogix Corp.
|
Jun 03, 2019 11:44AM
|
|
Re: We know...
|
1
|
Resverlogix Corp.
|
Jun 03, 2019 11:05AM
|
|
Re: A healthy debate....
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 10:56AM
|
|
Re: No doubt about it....
|
5
|
Resverlogix Corp.
|
Jun 03, 2019 07:57AM
|
|
Re: Buyout?......
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 07:50AM
|
|
Re: No doubt about it....
|
2
|
Resverlogix Corp.
|
Jun 03, 2019 07:41AM
|
|
Re: Buyout?......
|
4
|
Resverlogix Corp.
|
Jun 02, 2019 10:07PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
7
|
Resverlogix Corp.
|
Jun 02, 2019 08:37AM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Jun 01, 2019 11:49PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Jun 01, 2019 07:32PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
6
|
Resverlogix Corp.
|
Jun 01, 2019 07:10PM
|
